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Abstract
Background: National guidelines in the UK, United States of America, Canada, and Australia have recently stressed
the importance of identifying and treating antenatal anxiety and depression. However, there is little research into
the most effective and acceptable ways of helping women manage their symptoms of anxiety and stress during
pregnancy. Research indicates the necessity to consider the unique needs and concerns of perinatal populations to
ensure treatment engagement, highlighting the need to develop specialised treatments which could be integrated
within routine antenatal healthcare services. This trial aims to develop a brief intervention for antenatal anxiety, with
a focus on embedding the delivery of the treatment within routine antenatal care.
Methods/Design: This study is a two-phase feasibility trial. In phase 1 we will develop and pilot a brief intervention
for antenatal anxiety, blended with group support, to be led by midwives. This intervention will draw on cognitive
behavioural principles and wider learning from existing interventions that have been used to reduce anxiety in
expectant mothers. The intervention will then be tested in a pilot randomised controlled trial in phase 2. The following
outcomes will be assessed: (1) number of participants meeting eligibility criteria, (2) number of participants consenting
to the study, (3) number of participants randomised, (4) number of sessions completed by those in the intervention
arm, and (5) number of participants completing the post-intervention outcome measures. Secondary outcomes comprise:
detailed feedback on acceptability, which will guide further development of the intervention; and outcome data on
symptoms of maternal and paternal anxiety and depression, maternal quality of life, quality of couple relationship,
mother-child bonding, infant temperament and infant sleep.
Discussion: The study will provide important data to inform the design of a future full-scale randomised controlled
trial of a brief intervention for anxiety during pregnancy. This will include information on its acceptability and feasibility
regarding implementation within current antenatal services, which will inform whether ultimately this provision could
be rolled out widely in healthcare settings.
Trial registration: Current Controlled Trials ISRCTN95282830. Registered on 29 October 2014.
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Background
Clinically significant levels of anxiety symptoms are expe-
rienced by up to half of all women during pregnancy [1],
with a high proportion suffering diagnosed anxiety disor-
ders [2–4]; prevalence estimates for generalised anxiety
disorder in pregnancy range from 0 to 10.5 % [4]. Further-
more, antenatal anxiety is a strong predictor of postnatal
anxiety and depression [3, 5, 6]. There is now a substantial
body of evidence from observational cohort studies dem-
onstrating that elevated anxiety in mothers during preg-
nancy is also associated with an increased risk of a range
of short- and long-term adverse outcomes in their chil-
dren [7] and poorer obstetric outcomes [8]. These include
higher rates of preterm delivery [8, 9], and effects on
child outcomes such as difficult temperament [10, 11],
increased sleep problems [12], poorer cognitive func-
tioning [13], and higher rates of emotional and behav-
ioural problems in early childhood that often persist
into later development [7].
National guidelines in the UK [14], the United States
of America [15, 16], Canada [17], and Australia [18–20]
have recently stressed the crucial importance of identify-
ing and offering treatment for antenatal anxiety and de-
pression. These guidelines have recommended screening
for all women as a routine part of antenatal care, along
with timely access to appropriate services for assessment
and psychological intervention in pregnancy [14–20].
These recommendations were made despite the lack of
evidence to guide the direction of treatment for women
who have anxiety during pregnancy and the absence of
systematic research examining the impact of treating
antenatal anxiety on maternal and infant outcomes. This
missing link is critical, as the potential opportunity for
preventive intervention is large, given the substantial
neural, cognitive and socio-emotional developments that
occur in the fetal period and the first years of life [7],
and potential for recurrent problems in the mother.
It is, therefore, crucial that effective and cost-effective
treatments are developed for antenatal anxiety. Recent re-
search strongly suggests that perinatal populations have
unique concerns, and that considering the specific needs
of perinatal populations is essential to ensure treatment
engagement [21–23]. Any treatment for antenatal anxiety
must, therefore, be acceptable and relevant to pregnant
women, addressing their specific anxieties and unique cir-
cumstances and needs during this period. Cognitive Be-
havioural Therapy (CBT) has been subject to rigorous
evaluation and has a strong evidence base for the effective
treatment of anxiety disorders [24], including in a guided
self-help format [25], but a specific literature investigating
the utility of CBT approaches for treating anxiety during
pregnancy is largely lacking at present [26, 27]. One of
very few interventions that have been further developed
and evaluated for antenatal mood difficulties is Towards
Parenthood [28]. This is a guided self-help intervention de-
signed to help expectant parents prepare for parenthood,
which has been developed by Milgrom, Ericksen and col-
leagues in Australia. This has been tested in a clinical trial
[28] and showed promising results, with significant reduc-
tions in symptoms of both anxiety and depression at post-
natal follow-up compared to routine care.
Recent research has also highlighted the impact that
partners have on child development and family function-
ing [29], and the importance of social support during
pregnancy, since this is associated with lower maternal
antenatal and postnatal depression and anxiety [6, 30, 31].
More recent policy documents have indicated that preg-
nancy is an important opportunity to engage partners [32]
and have recommended the inclusion of fathers in care
and intervention from the antenatal period [33], suggest-
ing that interventions for maternal mental health in the
perinatal period should also consider the potential inclu-
sion of partners.
The advantages of intervening in the antenatal
period to reduce maternal anxiety are threefold: first,
the psychological treatment is delivered in a context in
which mothers are already experiencing a high level of
contact with healthcare services and frequently attend
routine antenatal classes; second, antenatal treatment
could reduce the possible negative effects of antenatal
anxiety on fetal development; and third, given the as-
sociations between antenatal anxiety and postnatal de-
pression and anxiety [3, 5, 6], antenatal intervention
offers the potential to prevent some episodes of post-
natal depression and anxiety and so to improve mater-
nal wellbeing, as well as reduce the developmental risk
to the child of exposure to maternal postnatal depres-
sion and anxiety.
Our research proposes the development and testing
of an intervention tailored specifically for use with
pregnant women experiencing antenatal anxiety, based
on CBT principles and incorporating key learning from
the Towards Parenthood team, for use in a group for-
mat led by midwives, in the context of UK antenatal
services. Embedding the intervention in routine ante-
natal care in a brief midwife-led group format means
that it has the potential to be a cost-effective mode of
delivery and one that is robust to changing healthcare
environments, requiring less time and input from mid-
wives than an individual psychological approach and
being widely available to women experiencing difficul-
ties with anxiety. It therefore has the potential to im-
prove outcomes for a wide range of pregnant women
and their infants, thereby reducing the overall popula-
tion burden of anxiety during pregnancy. Given the
existing national guidelines, the results of the proposed
trial could be crucial in informing the development of
clinical services.
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Aims and objectives
Following the Medical Research Council guidelines for
developing and testing complex interventions [34, 35],
the purpose of this research is to assess the feasibility
and acceptability of delivering a midwife-led group inter-
vention to reduce levels of anxiety in pregnant women.
The objective of phase 1 is to develop an intervention,
based on the principles outlined above, for use in the
UK in a group setting led by midwives. The objective of
phase 2 is to conduct a pilot randomised controlled trial
(RCT) comparing the group intervention with treatment
as usual. Outcomes will assess: the feasibility and accept-
ability of recruitment and data collection methods; the
acceptability of intervention materials and delivery; likely
recruitment and retention rates; and estimates of the
range of effect sizes. We will use this information to in-
form a fully powered RCT.
Methods/Design
Study design
The study consists of two phases. Phase 1 is a develop-
ment stage in which a brief intervention for anxiety will
be developed, adapted for pregnancy, drawing on core
CBT principles and learning from the team that devel-
oped the Towards Parenthood intervention [28]. We will
develop an intervention for delivery in group format, to
be led by midwives and embedded into antenatal care in
the UK. In an initial pilot group we will gather detailed
feedback about the intervention content and delivery,
and will use this information to inform further treatment
adaptations. A mixed-methodology design will be used. If
a manualised intervention can be successfully developed
and delivered to a pilot group in a way that is acceptable
to them, and/or modified to take any key suggestions and
concerns into account, we will continue to phase 2.
In phase 2, we will conduct a pilot RCT comparing the
group intervention for antenatal anxiety (intervention
group) with treatment as usual (control group). This proto-
col follows Consolidated Standards of Reporting Trials
(CONSORT) [36] and Standard Protocol Items: Recom-
mendations for Interventional Trials (SPIRIT) [37] (Add-
itional file 1) guidelines for reporting clinical trial protocols.
Study setting
Participants will be recruited through UK National
Health Service (NHS) antenatal scanning clinics at their
12-week scan in London and the South West of England.
The intervention will be delivered to participants in these
locations as a part of antenatal services.
Participant inclusion criteria
Eligible participants will be pregnant women who have
not had any children, entering their second trimester,
aged 18 and over. Women will be invited to participate
if they score in the top quartile of scores on the General-
ised Anxiety Disorder 7-item scale (GAD-7) [38] at screen-
ing. The GAD-7 is a 7-item self-report screening measure
for anxiety symptoms, which is widely-used in clinical
practice and research.
Partners of women who consent to take part in the
study will also be invited to participate. Fully informed
consent will be obtained from potential participants for
each stage of the research.
Participant exclusion criteria
Potential participants will be excluded if: they have insuffi-
cient understanding of English to complete the interven-
tion or outcome measures; they have a significant illness
or disability that would make it difficult for them to
participate.
Recruitment procedure
After completing the screening questionnaire for anxiety
(GAD-7; [38]) and a small number of demographic ques-
tions in the antenatal scanning clinic, women who meet
eligibility criteria will be sent information on the full study
and a consent form. A researcher will follow up with a
phone call and, if the individual is willing to take part, will
guide them through the consent form. The participant will
be directed to send back the signed consent form via mail
or online, after which the researcher will provide the par-
ticipant with the option to complete the baseline question-
naires via mail or online. Upon completion and receipt of
the baseline measures, participants will be randomised
(see Fig. 1). Women’s partners who agree to participate in
the study will be consented separately.
All participants will be offered a £10 voucher at three
time points in the study as an expression of gratitude for
their participation and will be reimbursed any travel ex-
penses incurred.
Randomisation
In phase 2, participants will be randomly allocated on a
1:1 basis to either the intervention group or the treat-
ment as usual group using a sealed envelope method,
managed by a staff member in a separate research group.
Participants will be informed of their group allocation by
a researcher over the telephone.
Sample size
In line with guidelines for pilot RCTs, no formal power
calculation has been conducted [39]. A sample size of 30
participants per arm is recommended for feasibility studies
as providing sufficient data to gain an accurate estimation
of the feasibility and acceptability of the intervention and
trial methods [40], and to provide a reasonable range of es-
timates of the sample size required for a definitive RCT
[41]. Thus, 30 participants will receive the intervention (in
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four groups of approximately 7–8 participants each, plus
participants’ partners where possible) and 30 will receive
treatment as usual.
Intervention
The research will adapt and build on existing interven-
tions utilising CBT principles. One such intervention,
Towards Parenthood, is a workbook-based, psychoedu-
cational intervention that focuses on making the transi-
tion into parenthood and on the emotional, social and
psychological issues that can arise during pregnancy and
early parenthood. The Towards Parenthood intervention
aims to help expectant parents develop effective coping
and parenting skills. In addition, it provides specific in-
formation about anxiety, stress and mood problems and
incorporates fundamental elements of CBT, which ad-
dresses maladaptive cognitions and behaviours. In a clin-
ical trial in Australia [28] it was shown to be effective in
reducing symptoms of anxiety (d = 0.58), stress (d = 0.59)
and depression (d = 0.6) in women at postnatal follow-up.
The workbook incorporates nine sections and women in
the Australian trial additionally received weekly telephone
support from trained psychologists or postgraduate psych-
ology trainees.
The planned intervention will be developed for opti-
mal efficacy, feasibility and acceptability with a broad
population of pregnant women experiencing a range of
anxiety symptoms of differing severity, with the aim of
reducing the overall population burden of antenatal
anxiety.
The proposed format will be a manualised brief inter-
vention, blended with group support. We plan to deliver
three group sessions in the antenatal period, led by a
trained midwife and psychology supporter, with each
session lasting approximately 90 minutes. Sessions will
be held at 3-week intervals, which is designed to main-
tain participant engagement but also allow participants
enough time to try out practical strategies between ses-
sions. As a further measure to support participants and
maintain engagement, the midwife and psychologist de-
livering the groups will also send a weekly email to each
participant to remind them to practise the skills from
the previous group session and to ask whether they have
any questions about the material. This can be stepped
up to a telephone call if there is no response from a par-
ticipant or if a telephone call is requested by the partici-
pant. Telephone calls will be limited to a maximum of
15 minutes in length, unless clinical imperative dictates
otherwise.
The three group sessions are designed to address spe-
cific antenatal anxieties, and will support participants in
developing key practical skills. A group mode of delivery
has strong potential to be more cost-effective and sus-
tainable and less time-consuming for midwives than in-
dividual support, and will also enable mutual support
and interaction between group members, thereby fitting
well with the existing models of antenatal care. Further-
more, it could be easily integrated into current routine
NHS antenatal services and would, therefore, be widely
available and accessible to a broad range of pregnant
women. The specific parameters of the intervention and
its delivery will be finalised in light of the pilot work
undertaken in phase 1 of the research programme, but the
aim is to base the three group sessions on a number of
key themes, including psychoeducation on anxiety during
pregnancy, problem-solving, communication and other
strategies and techniques to help with managing anxiety
and stress including self-care and compassion (Fig. 2).
In the first two sessions, participants will be split into
separate groups for part of the session: one group for
pregnant women and the other for partners. This will
allow pregnant women to work on specific skills to help
with their anxiety, whilst partners will work on skills
and approaches to support their pregnant partner. The
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) flow
diagram of progress through the study
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remainder of each session, and the entire third session,
will be delivered to the group as a whole, to allow cou-
ples to develop coping strategies together. At the end
of the three group sessions support moves to be more
self-led and participants will be given the full Towards
Parenthood workbook to work through. There will also
be a follow-up session for participants at approximately
8 weeks postnatally. This will be an informal session
which will give participants a chance to meet again and
to check in with the midwives.
All women in the intervention arm will continue to
receive their usual care during pregnancy, and will have
access to the usually available range of interventions for
antenatal anxiety and other physical and mental health
problems.
Control: treatment as usual
Women randomised to the control group will continue to
receive their usual care for antenatal anxiety. Although
there is currently no standard model of care for antenatal
anxiety, this may include care provided by their general
practitioner (GP), midwife, health visitor, local Improving
Access to Psychological Therapies (IAPT) service or com-
munity mental health team. The care received by women
in the trial will be actively monitored by the research
group, using the Adult Service Use Scale (AD-SUS).
Assessments and outcome measures
Feasibility and acceptability
The main study outcomes will assess the feasibility and ac-
ceptability of the intervention and study design. The pri-
mary outcome will be feasibility of recruitment and data
collection, examined through assessing the following:
(1) number of participants meeting eligibility criteria,
(2) number of participants consenting to the study, (3)
number of participants randomised, (4) number of sessions
completed by those in the intervention arm, and (5) num-
ber of participants completing the post-intervention out-
come measures. Furthermore, we will record reasons for
study withdrawal, non-participation and non-attendance of
intervention sessions.
Detailed feedback will be gathered from all participants
and the midwife and psychologist delivering the interven-
tion, in order to assess the acceptability of the intervention
and trial methods. Feedback will be gained from partici-
pants allocated to the intervention arm through brief ques-
tionnaires at the end of each group session and a more
detailed post-intervention feedback questionnaire. Semi-
structured acceptability interviews will be conducted with
a purposeful sample of participants from both study arms
at post-intervention assessment. Open-ended questions
will be asked about participants’ impressions of the
intervention and group delivery; the relevance and suit-
ability of the intervention content; perceived benefit of
the intervention; problems or difficulties experienced
with the sessions, and recommendations for changes or
developments to the intervention; their experience of
being a part of the study; and their impressions of current
routine antenatal care. Interviews are designed to last
approximately 30–60 minutes and will be conducted face-
to-face. Qualitative data analysis will be conducted follow-
ing the interviews.
Fidelity to the intervention manual will be examined
using video and audio tapes of intervention sessions. A
random sample of 10 % of therapy tapes will be assessed
for fidelity by two of the investigators.
Data collection
At each assessment point, questionnaires will either be
posted to participants and returned via post, or partici-
pants will be provided with a link to a website where
they can complete the measures online. Measures will
be collected at baseline, post intervention (10 weeks post
randomisation), 8 weeks post intervention (18 weeks post
randomisation), and postnatal follow-up (34 weeks post
randomisation); the measures of mother-child relation-
ship, infant temperament and infant sleep will be collected
at postnatal follow-up only. Partners will also complete
Fig. 2 Focus of midwife-led group support sessions
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measures of anxiety, mood and quality of couple relation-
ship at each assessment point.
Clinical outcome measurements
A range of clinical outcome measures will be included in
order to assess the feasibility and acceptability of these
measures, and estimates of levels of symptoms in both
trial arms at each assessment time point. Measures of
the following will be included:
1. Maternal anxiety, using the GAD-7 [38], a 7-item
scale measuring symptoms of generalised anxiety
disorder. The GAD-7 has excellent internal
consistency (Cronbach’s α = .92) and good test-retest
reliability (intraclass correlation = 0.83) [38]. When
used in perinatal populations the GAD-7 has yielded
a sensitivity of 61.3 % and specificity of 72.7 %, using
a cut-off score of 13 [42]
2. Maternal mood, using the Edinburgh Postnatal
Depression Scale (EPDS) [43], a 10-item self-report
scale used to assess antenatal and postnatal depres-
sion [43–45]. The EPDS has a high level of test-
retest reliability (intraclass correlation = 0.92) [46].
In the second trimester of pregnancy the sensitivity
of the EPDS is estimated to be 88 % and the specifi-
city 91 %, when using a cut-off score of 9/10 [44]
3. Pregnancy-specific worries, using the 10-item
pregnancy-related anxiety scale [47]. The pregnancy-
related anxiety scale has acceptable internal reliability
(Cronbach’s α = .78) [47]
4. Couple relationship, using the Dyadic Adjustment Scale
(DAS) [48], a 32-item self-report measure of relation-
ship adjustment. The DAS has been reported to have
excellent internal consistency (Cronbach’s α = .915) [49]
5. Birth outcomes, using an 8-item maternal self-report
questionnaire, developed for this study
6. Mother-child relationship, using the 25-item Postpar-
tum Bonding Questionnaire (PBQ) [50]. The PBQ has
been demonstrated to have acceptable internal
consistency (Cronbach’s α = .76) [51]. For identifica-
tion of any disorder of the mother-infant relation-
ship the PBQ has yielded a specificity of 74 % and
sensitivity of 84 % [52]
7. Infant temperament, using a modified version of the
Infant Behaviour Questionnaire (IBQ) [53]. Each
subscale of the IBQ has been reported to have
acceptable or good internal reliability: activity
level (α = .73), smiling and laughter (α = .85), fear
(α = .80), distress to limitations (α = .84), soothability
(α = .84), and duration of orienting (α = .72) [53]
8. Infant sleep, using the Brief Infant Sleep
Questionnaire [54]. This questionnaire has good
test-retest reliability; significant correlations are
reported between the repeated sleep measures
for daytime sleep duration (r = .89), settling time
(r = .94), nocturnal sleep-onset time (r = .95),
nocturnal sleep duration (r = .82), number of night
wakings (r = .88), and duration of nocturnal
wakefulness (r = .95) [54]
9. Health-related quality of life of the mother, using the
EuroQol-5D-3 L measure [55] recommended by
National Institute for Health and Care Excellence
(NICE) for inclusion in economic evaluations
10. Health economics: the economic component of the
proposed work will involve use of the Adult Service
Use Schedule (AD-SUS) [56], a questionnaire
designed for application to mental health
populations, including depression and anxiety
Data analysis
Quantitative data analysis
Data analysis will be primarily descriptive to aid the
planning of a future RCT. Participant flow through the
study will be presented following CONSORT guidelines
[36]. Descriptive data will be presented in the form of
means and standard deviations; medians and ranges; or
percentages with 95 % confidence intervals, as appropriate
depending on the data being described. The following will
be calculated: (1) percentage of participants meeting eligi-
bility criteria, (2) percentage of individuals consenting to
the study, (3) percentage entering the randomisation phase,
(4) the number of sessions completed by those in the
treatment arm, (5) percentage completing the outcome
measures at post-treatment follow-up, (6) between group
pre-post effect sizes and confidence intervals on the
GAD-7 and EPDS.
Qualitative data analysis
Qualitative interviews following the treatment groups will
be transcribed verbatim. Transcripts will be analysed in
detail using thematic analysis [57], informed by grounded
theory methods. Atlas® software will be used to assist in
organising content related to themes.
Data management
Data will be stored in line with NHS ethical procedures
and a standard protocol is in place to outline data stor-
age and security procedures. Participants’ questionnaires
will be coded with a numerical identifier and kept separ-
ately from any identifiable personal information such as
names or addresses. Data quality will be checked using
double data entry for 10 % of the data and standard data
management protocols will be followed.
Safety monitoring and reporting
A standard protocol is in place to deal with situations in
which a participant reports risk to themselves or others.
This protocol outlines the response of the researcher
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and necessary steps to take in order to ensure safety of
the participant and others and to establish contact with
caregivers or emergency support. If there are concerns
about a child’s safety, a standard protocol for dealing
with child protection issues will be followed. All risk or
safety issues will be reported to the principal investigator,
who will take any necessary further steps and provide on-
going clinical supervision to members of the research
team. The same protocol will be followed should partici-
pants disclose any information which is concerning to the
research team, or if they score highly (at risk) on the ques-
tionnaire assessing mood (EPDS) (Additional file 2).
Debriefing sessions and clinical supervision with the
individuals delivering the intervention will take place
regularly.
If a participant’s condition should worsen or a co-morbid
condition become apparent during the course of the trial
the study team would refer the participant to existing
healthcare services for additional treatment. In line with
ethical guidelines, participants will be informed that should
they wish to discontinue with the intervention they can
withdraw at any point. If further care for any participant is
needed post trial, the study team will refer the participant
to existing healthcare services.
Any serious adverse events will be recorded and re-
ported to the sponsor, the hosting NHS trust and to the
ethics committee as appropriate.
Ethical approval
The trial received ethical approval from the London –
Riverside National Research Ethics Service on 15 April
2014 (Research Ethics Committee reference number: 14/
LO/0339). The trial will be conducted in accordance with
the Data Protection Act at all times. The participants will
be identified by a study specific participant number in all
databases. Names and any other identifying detail will not
be included in any study data electronic file. Where sam-
ple sizes are very small extra care will be taken to ensure
that individual participants cannot be identified from the
research data.
Dissemination
A range of dissemination strategies will be used:
1. A summary report and presentations on study
findings will be prepared for clinical services,
particularly primary care GP surgeries and maternity
services. A presentation of findings will also be
planned for clinical conferences and the annual
Clinical Research Network conference
2. The trial team will present findings at relevant
national and international conferences, and will
submit papers on the feasibility RCT results and
acceptability interviews to peer-reviewed journals.
A full study report will be submitted to the
National Institute for Health Research (NIHR)
3. The Patient and Public Involvement advisory group
will advise and support on dissemination to service
users. This will be achieved through our existing
networks, which include close collaborations with
national parenting websites, and through further
contacts developed with this project
4. Newsletters and a summary of results will be
prepared for stakeholder organisations, including
those on the trial advisory group. Media releases and
talks to non-specialist audiences will also be planned
5. Regular newsletters and a final summary report of
trial findings will be sent to all study participants
Discussion
This two-phase feasibility study is designed to assess
questions of feasibility and acceptability, in order to in-
form the design of a potential future substantive RCT.
Detailed acceptability feedback will inform the further
development of the intervention.
This group intervention led by midwives has the poten-
tial to be an acceptable, effective and cost-effective inter-
vention for anxiety and stress during pregnancy. If effective
it could improve short- and long-term outcomes for
both mother and child, and reduce the overall popula-
tion burden of anxiety during pregnancy. It is designed
to fit alongside existing antenatal services and could,
therefore, potentially be rolled out widely across the NHS.
Trial status
Recruitment is ongoing, and began in November 2014.
Additional files
Additional file 1: SPIRIT Checklist. (PDF 130 kb)
Additional file 2: Standard Operating Procedure where participant has
elevanted levels of depressive symptoms. (PDF 386 kb)
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